Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechSci Research | PRODUCT CODE: 1881462

Cover Image

PUBLISHER: TechSci Research | PRODUCT CODE: 1881462

Rapid Medical Diagnostic Kits Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Over the Counter Kits, Professional Kits), By Application, By End-use Region and Competition, 2020-2030F

PUBLISHED:
PAGES: 180 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4500
PDF and Excel (Multi-User License)
USD 5500
PDF and Excel (Custom Research License)
USD 8000

Add to Cart

We offer 8 hour analyst time for an additional research. Please contact us for the details.

The Global Rapid Medical Diagnostic Kits Market, valued at USD 16.62 Billion in 2024, is projected to experience a CAGR of 9.05% to reach USD 27.95 Billion by 2030. Rapid Medical Diagnostic Kits (RDKs) are portable in vitro diagnostic devices designed to deliver prompt, qualitative or semi-quantitative test results at the point of care, often without the need for extensive laboratory infrastructure or specialized training. The market for these kits is primarily driven by the increasing prevalence of infectious and chronic diseases, coupled with a growing emphasis on early disease detection and decentralized testing solutions.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 16.62 Billion
Market Size 2030USD 27.95 Billion
CAGR 2025-20309.05%
Fastest Growing SegmentInfectious Disease Testing
Largest MarketNorth America

Key Market Drivers

The escalating global burden of infectious and chronic diseases significantly underpins the expansion of the rapid medical diagnostic kits market by necessitating prompt and accessible diagnostic tools. Early detection is crucial for effective disease management and outbreak control, driving the adoption of solutions that offer quick results without extensive laboratory infrastructure. For instance, according to the Centers for Disease Control and Prevention, in 2024, more than 12 million dengue cases were reported, marking it as the highest year on record, underscoring the urgent need for rapid diagnostics in managing such widespread infectious threats.

Key Market Challenges

The stringent and varied regulatory approval processes across different regions present a substantial impediment to the growth of the Global Rapid Medical Diagnostic Kits Market. These complex frameworks often necessitate extensive documentation, prolonged review periods, and substantial investment in compliance, creating significant barriers for manufacturers seeking to introduce new diagnostic solutions. The lack of harmonized regulations across major markets further exacerbates these challenges, requiring manufacturers to navigate multiple distinct and often overlapping requirements.

Key Market Trends

Integration with digital health platforms and AI analytics represents a transformative shift in the rapid medical diagnostic kits market, moving beyond simple result generation to comprehensive data interpretation and patient management. This trend leverages artificial intelligence to enhance diagnostic accuracy, predict disease progression, and personalize treatment pathways by analyzing vast datasets from various diagnostic points. According to MedTech Europe, in 2024, Germany's Digital Health Applications (DiGA) pathway saw an 85% utilization rate of prescribed digital health solutions, indicating significant patient and clinician adoption of digitally integrated healthcare tools.

Key Market Players

  • Artron Laboratories Inc.
  • Alfa Scientific Designs, Inc.
  • BD and Company
  • bioMerieux SA
  • BTNX, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Cardinal Health Inc.
  • Creative Diagnostics
  • F. Hoffmann-La Roche AG

Report Scope:

In this report, the Global Rapid Medical Diagnostic Kits Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Rapid Medical Diagnostic Kits Market, By Product:

  • Over the Counter (OTC) Kits
  • Professional Kits

Rapid Medical Diagnostic Kits Market, By Application:

  • Blood Glucose Testing
  • Infectious Disease Testing
  • Cardiometabolic Testing
  • Pregnancy and Fertility Testing
  • Fecal Occult Blood Testing
  • Coagulation Testing
  • Toxicology Testing
  • Lipid Profile Testing
  • Other Applications

Rapid Medical Diagnostic Kits Market, By End Use:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Rapid Medical Diagnostic Kits Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Rapid Medical Diagnostic Kits Market.

Available Customizations:

Global Rapid Medical Diagnostic Kits Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Product Code: 21908

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Rapid Medical Diagnostic Kits Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Over the Counter (OTC) Kits, Professional Kits)
    • 5.2.2. By Application (Blood Glucose Testing, Infectious Disease Testing, Cardiometabolic Testing, Pregnancy and Fertility Testing, Fecal Occult Blood Testing, Coagulation Testing, Toxicology Testing, Lipid Profile Testing, Other Applications)
    • 5.2.3. By End Use (Hospitals, Ambulatory Surgical Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Rapid Medical Diagnostic Kits Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End Use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Rapid Medical Diagnostic Kits Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End Use
    • 6.3.2. Canada Rapid Medical Diagnostic Kits Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End Use
    • 6.3.3. Mexico Rapid Medical Diagnostic Kits Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End Use

7. Europe Rapid Medical Diagnostic Kits Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End Use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Rapid Medical Diagnostic Kits Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End Use
    • 7.3.2. France Rapid Medical Diagnostic Kits Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End Use
    • 7.3.3. United Kingdom Rapid Medical Diagnostic Kits Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End Use
    • 7.3.4. Italy Rapid Medical Diagnostic Kits Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End Use
    • 7.3.5. Spain Rapid Medical Diagnostic Kits Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End Use

8. Asia Pacific Rapid Medical Diagnostic Kits Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End Use
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Rapid Medical Diagnostic Kits Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End Use
    • 8.3.2. India Rapid Medical Diagnostic Kits Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End Use
    • 8.3.3. Japan Rapid Medical Diagnostic Kits Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End Use
    • 8.3.4. South Korea Rapid Medical Diagnostic Kits Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End Use
    • 8.3.5. Australia Rapid Medical Diagnostic Kits Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End Use

9. Middle East & Africa Rapid Medical Diagnostic Kits Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End Use
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Rapid Medical Diagnostic Kits Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End Use
    • 9.3.2. UAE Rapid Medical Diagnostic Kits Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End Use
    • 9.3.3. South Africa Rapid Medical Diagnostic Kits Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End Use

10. South America Rapid Medical Diagnostic Kits Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End Use
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Rapid Medical Diagnostic Kits Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End Use
    • 10.3.2. Colombia Rapid Medical Diagnostic Kits Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End Use
    • 10.3.3. Argentina Rapid Medical Diagnostic Kits Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Rapid Medical Diagnostic Kits Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Artron Laboratories Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Alfa Scientific Designs, Inc.
  • 15.3. BD and Company
  • 15.4. bioMerieux SA
  • 15.5. BTNX, Inc.
  • 15.6. Bio-Rad Laboratories, Inc.
  • 15.7. Danaher Corporation
  • 15.8. Cardinal Health Inc.
  • 15.9. Creative Diagnostics
  • 15.10. F. Hoffmann-La Roche AG

16. Strategic Recommendations

17. About Us & Disclaimer

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!